Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ORB-204
- Development stage
- Preclinical
- Lead developer
- Daré Bioscience
- Administration
- Injectable
01
Overview
ORB-204 is an investigational drug candidate in active preclinical or early clinical development. It is part of a portfolio of products, including ORB-204 and ORB-214, that are being advanced to address unmet needs in women's health. ORB-204 is being developed by Daré Bioscience, as part of its strategic collaboration and licensing activities. Detailed information regarding its exact composition, mechanism of action, or indications has not been publicly disclosed as of October 2025, but it is positioned within Daré Bioscience’s women’s health pipeline and referenced as an innovative therapeutic candidate[5][8].
- Other names
- ORB-204ORB204ORB 204
Beyond the preview
Go deeper on ORB-204.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ORB-204.